tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Pete Stavropoulos, 59 are a BUY (93.65%), 4 are a HOLD (6.35%).
Analyst Pete Stavropoulos, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 26% that have a potential upside of 78.94% achieved within 168 days.
Pete Stavropoulos’s has documented 101 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RZLT, Rezolute at 06-Oct-2026.
Analyst best performing recommendations are on ORTX (ORCHARD THERAPEUTICS PLC).
The best stock recommendation documented was for ORTX (ORCHARD THERAPEUTICS PLC) at 6/27/2023. The price target of $15 was fulfilled within 100 days with a profit of $9.77 (186.81%) receiving and performance score of 18.68.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Apr-2024
$15
$11.59 (339.88%)
$14
22 days ago
(30-Sep-2026)
1/7 (14.29%)
$10.77 (254.61%)
188
Buy Since 25-Jan-2021
$25
$21.59 (633.14%)
$11
3 months 7 days ago
(15-Jul-2026)
0/17 (0%)
$18.5 (284.62%)
Buy Since 20-Mar-2026
$16
$10.52 (191.97%)
$16
7 months 2 days ago
(20-Mar-2026)
0/2 (0%)
$10.89 (213.11%)
Buy Since 30-Nov-2021
$14
$10.59 (310.56%)
7 months 2 days ago
(20-Mar-2026)
0/4 (0%)
$8.89 (173.97%)
Buy Since 27-Mar-2024
$27
$21.52 (392.70%)
$14
11 months 3 days ago
(19-Nov-2025)
0/5 (0%)
$22.94 (565.02%)
Which stock is Pete Stavropoulos most bullish on?
What Year was the first public recommendation made by Pete Stavropoulos?
